Skip to main navigation

Shockwave Medical

Technology
- Challenges of Calcium
- Intravascular Lithotripsy (IVL)
Clinicians
- USA
- Peripheral
- Coronary
- Valve
- International
- Peripheral
- Coronary
- Valve
Investors
About
- Our Story
- People
- Careers
- Patents
- Press Releases
- The Catalyst
Contact

Technology
- Challenges of Calcium
- Intravascular Lithotripsy (IVL)
Clinicians
- USA
- Peripheral
- Coronary
- Valve
- International
- Peripheral
- Coronary
- Valve
Investors
About
- Our Story
- People
- Careers
- Patents
- Press Releases
Contact

Home / Investors / News & Events / Presentations

Investor Relations
Shareholder Tools

Presentations

Presentations

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Investor Presentation August 2020

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

Technology
- Challenges of Calcium
- Intravascular Lithotripsy (IVL)
Clinicians
- US
- Peripheral
- Coronary
- Valve
- International
- Peripheral
- Coronary
- Valve
About Us
- Our Story
- People
- Careers
- Patents
- Press Releases
- The Catalyst
Investor
Contact Us

Follow Us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

Footer

Privacy Policy
Patents
Peripheral ISI
Coronary ISI

© 2020 Shockwave Medical, Inc. All rights reserved. | SPL 62656 Rev. A